As of 2025-08-02, the EV/EBITDA ratio of HTG Molecular Diagnostics Inc (HTGM) is -0.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HTGM's latest enterprise value is 4.96 mil USD. HTGM's TTM EBITDA according to its financial statements is -20.23 mil USD. Dividing these 2 quantities gives us the above HTGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 11.7x | 9.8x |
| Forward P/E multiples | 5.6x - 11.4x | 7.4x |
| Fair Price | (67.19) - (106.30) | (80.58) |
| Upside | -14097.7% - -22245.9% | -16886.7% |
| Date | EV/EBITDA |